Login
$GNLX
$2.05 +$0.14 (7.33%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
ASSETS
Current assets:
Short-term investments
Cash, cash equivalents and restricted cash
Marketable securities
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Right of use assets
Long-term investments
Other assets
Total Other Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses
Accrued payroll and payroll taxes
Accrued interest payable - director and shareholders
Lease liabilities, current portion
Convertible notes payable - shareholders, current portion
Total current liabilities
Lease liabilities, long-term portion
Total liabilities
Stockholders’ equity:
Common stock, par value $0.001, 200,000,000 shares authorized; 45,103,461 and 38,139,144 shares issued and outstanding, respectively
Treasury stock, 433,333 shares, at cost
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support